Considerations & Progress in Developing a Dual TLR Agonist

Time: 12:30 pm
day: Day One

Details:

  • Exploring the drug discovery process: target identification & validation, antitumor effect, pathway understanding, biomarkers
  • Discussing potential indications?
  • Latest data & future directions

Speakers: